CD13 Leukemia Cell Marker

The CD13 leukaemia cell marker test is done to determine if the patient has multiple solid tumours in their body. This test looks for the presence of CD13 cells, commonly known to be associated with leukaemia.

Cell markers are usually created by cancer cells or other cells in the body in response to cancer. Each marker is used to point toward a different form of cancer. For instance, the presence of CD13 cells points to leukaemia which is a cancer of the blood-forming tissues that includes the bone marrow and the lymphatic system.

The condition of leukaemia may exist in many forms and may not be immediately detectable. However, an individual should consult the doctor if they are consistently exhibiting the following symptoms:

• Fever or chills
• Persistent fatigue and weakness all over the body
• A noticeable loss in weight without trying
• Regular and severe infections
• Recurrent nosebleeds
• Enlarged liver or spleen
• Excessive sweating, especially at night
• Easy bleeding or bruising on the body
• Swollen lymph nodes
• Tiny red spots on the skin

Decoding these symptoms early may help devise an early treatment plan to combat the ailment better.

The procedure for a CD13 leukaemia cell marker test is no different from a standard blood test. For this cell marker test, the lab professional draws blood from the vein or artery in your hand. The results help the doctor devise the course of treatment. The CD13 cell marker test helps in the following ways:

• It tracks the level of the cell markers, if already diagnosed.
• The results can help determine if the cancer is isolated or spreading rapidly.
• Given that the treatment is successful, the cell marker test can help determine if leukaemia has returned or not.
• It helps screen people for leukaemia, especially if they have a family history of cancer.

Apollo 24|7 offers a comprehensive CD13 leukaemia cell marker test. Before taking the test, no special preparation is required. However, it is better to consult a doctor or physician before discussing the patient’s medical history or medications that may interfere with the test.

Medically reviewed by Dr. Sanjaya Kumar Mishra, radiation oncologist from Apollo Hospitals Old Sainik School Road,Bhubaneswar.